George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lidco upbeat after 'excellent' second half performance

Thu, 13th Feb 2020 16:00

(Sharecast News) - Haemodynamic monitoring company Lidco updated the market on its just-ended financial year on Thursday, reporting that it continued to make progress with developing a strong recurring revenue base through its software-as-a-service (SaaS) high usage programme (HUP) model, and had achieved an "excellent" second half performance.
The AIM-traded firm said its product revenues for the 12 months ended 31 January were up 19% to ?7.4m, which was in line with management expectations.

It said the growth in Lidco product revenues "more than outweighed" the expected reduction in low margin third-party product sales.

As a result, total revenues, including third party products, were up 3% at ?7.6m, with the board explaining that the increased proportion of higher-margin Lidco revenues led to an increase in overall gross margin.

The company said it now had a global contracted base of 286 HUP monitors, up from 164 at the end of the 2019 financial year, generating total annualised contracted licence revenues of ?2.2m, which was an increase of 57%.

It said the 19% growth in 2020 financial year Lidco product sales reflected growth in all regions compared with the prior year.

Lidco product sales grew 28% in the United States to ?1.8m, 1% in the UK to ?3.6m, and sales outside of the firm's direct markets were up 60% to ?2.0m.

The directors said the "significant" growth outside the UK included ?0.4m growth in China from the launch of the new monitor, and as a result, sales outside the UK now represented "just over half" of Lidco product sales, up from 43% a year ago.

In the second half of the year there was a net cash inflow of ?0.2m, compared with a net cash outflow of ?0.5m in the first half.

The company said its balance sheet remained "strong", with cash balances as at 31 January totalling ?1.4m, down from ?1.7m, while the firm remained debt free.

Its board said it was expecting to report positive adjusted EBITDA for the 2020 financial year, compared to an EBITDA loss of ?1.2m in the 2019 financial year.

"After a strong first half in the 2020 financial year, the team succeeded in delivering an even better second half performance," said chief executive officer Matt Sassone.

"Our differentiated SaaS business model continues to drive our growth with the number of HUP monitors installed globally increasing nearly 75% and this has contributed to our expansion in recurring revenues."

Sassone said he was also pleased with the company's international sales growth, as it now had the majority of its Lidco product sales outside the UK, where it retained its market share and leadership position.

"This excellent performance leads to the expectation that we will report positive adjusted EBITDA for the 2020 financial year."

Lidco said it would announce its audited results for the year ended 31 January on 21 April.

At 1447 GMT, shares in Lidco were up 11.26% at 5.28p.
More News
21 Apr 2016 09:22

LiDCO Launches LiDCOunity Monitor At US Medicine Conference

Read more
13 Apr 2016 11:15

CORRECT (12 Apr): LiDCO Swings To Annual Loss As Sales Slip

Read more
12 Apr 2016 10:27

Lidco swings to yearly loss

(ShareCast News) - Blood monitoring company Lidco Group swung to a pre-tax loss for the year ended 31 January 2016 as revenue slid. The group reported a pre-tax loss of £578,000 compared with a £238,000 profit the year before, on revenue of £7.6m, down from £8.3m as it sold and placed 40% fewer moni

Read more
12 Apr 2016 09:19

WINNERS & LOSERS SUMMARY: Anglo American Sparkles On De Beers Sales

Read more
12 Apr 2016 09:02

LiDCO Swings To Annual Loss As Sales Slip; Renews Argon Contract

Read more
6 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Apr 2016 15:02

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Apr 2016 09:41

WINNERS & LOSERS SUMMARY: Landore Leaps On Canadian Gold Discovery

Read more
4 Apr 2016 08:05

LiDCO Group Wins US FDA Clearance For Latest Product

Read more
29 Mar 2016 07:27

LiDCO Gets Chinese Approval For LiDCO Rapid Monitor Sales

Read more
24 Mar 2016 09:17

LiDCO Signs Distribution Deals For Southern Africa, India And Malaysia

Read more
8 Feb 2016 14:52

Delayed purchases hurt LiDCO at year-end

(ShareCast News) - LiDCO was still facing challenges at the end of the financial year, as a number of customers slid large orders through past 31 January. The AIM-traded cardiovascular monitoring company said that, while it had a stronger second half, total revenues for the full year were lower than

Read more
8 Feb 2016 09:30

LiDCO Group To Report Fall In Revenue As Sales Slip Into New Year

Read more
23 Nov 2015 09:04

LiDCO Signs Master Distribution Deal For Asia Pacific With Fieldman

Read more
13 Oct 2015 09:27

Lidco signs purchasing agreement with US-based MedAssets

(ShareCast News) - Cardiovascular monitoring group Lidco Group has been awarded a five-year purchasing agreement by MedAssets, which is a US-based group purchasing organisation. MedAssets is a healthcare performance improvement company that serves four out of five hospitals in the US, and has awarde

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.